Kenneth d’Entremont
Fortune : 4 M $ au 31/05/2026
Fortune : 4 M $ au 31/05/2026
Kenneth d’Entremont was the founder of Medexus, Inc., founded in 2000, where the titles held included President, Chief Executive Officer & Director from 2000 to 2018.
The current job is Chief Executive Officer & Director at Medexus Pharmaceuticals, Inc. starting in 2018.
Former job includes General Manager & VP-Business Development at Sanofi Canada, Inc. from 1984 to 1999.
Education includes undergraduate studies at McMaster University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/12/2025 | 1 504 807 ( 4,66 % ) | 4 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Directeur Général | 17/12/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
Medexus, Inc.
Medexus, Inc. Drugstore ChainsRetail Trade Engages in licensing, registration, marketing, sales and distribution of pharmaceutical products | Fondateur | 17/12/2018 |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01/01/1999 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medexus Pharmaceuticals, Inc.
Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes pharmaceutical products | Health Technology |
Medexus, Inc.
Medexus, Inc. Drugstore ChainsRetail Trade Engages in licensing, registration, marketing, sales and distribution of pharmaceutical products | Retail Trade |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national